NEOADJUVANT IMMUNOTHERAPY
Clinical trials for NEOADJUVANT IMMUNOTHERAPY explained in plain language.
Never miss a new study
Get alerted when new NEOADJUVANT IMMUNOTHERAPY trials appear
Sign up with your email to follow new studies for NEOADJUVANT IMMUNOTHERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope: drug before surgery may stop merkel cell cancer spread
Disease control Recruiting nowThis study tests whether giving the drug cemiplimab before lymph node surgery can prevent Merkel cell carcinoma from spreading to nearby lymph nodes. About 135 adults with early-stage cancer will receive either the drug or a placebo before their scheduled biopsy. The goal is to s…
Matched conditions: NEOADJUVANT IMMUNOTHERAPY
Phase: PHASE2 • Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New drug cocktail shows promise for Tough-to-Treat urinary tract cancer
Disease control Recruiting nowThis phase 2 trial is testing two drugs—tislelizumab and disitamab-vedotin—given before surgery for a rare cancer of the upper urinary tract (UTUC) that is HER2-positive and high-risk. The goal is to see if the combination can shrink or eliminate tumors, making surgery more effec…
Matched conditions: NEOADJUVANT IMMUNOTHERAPY
Phase: PHASE2 • Sponsor: Tianjin Medical University Second Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC